Four petals evisceration for atrophia bulbi
Molham A. Elbakary
Abstract
Molham A. Elbakary
Abstract
PURPOSE: To study the use of four petals evisceration in atrophia bulbi to allow insertion of large orbital implant. MATERIALS AND METHODS: An interventional case series. All cases were atrophia bulbi. The axial lengths (AL) of atrophic and contralateral normal eye were measured. It was planned to use implant 3 mm smaller than AL of the contralateral normal eye. Four petals evisceration was used in all cases. RESULTS: Twenty cases were included. The mean age was 27.08 ± 16.07 years. The mean axial length (AL) of atrophic eyes was 16.97 ± 1.42 mm. In 75% of cases, the planned implant was inserted. In all cases, the implant diameter was larger than AL of atrophic eye by a mean of 2.57 ± 0.64 mm. The AL of atrophic eye did not affect the implant size. The mean follow-up period was 22.4 ± 10.1 months. Implant exposure was not recorded in any case. Volume deficiency was recorded in 2 cases (10%). CONCLUSIONS: Four petals evisceration facilitated the use of suitable sized implant in atrophia bulbi with minimal complications.
OpenAlex reports 9 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
PURPOSE: To study the use of four petals evisceration in atrophia bulbi to allow insertion of large orbital implant. MATERIALS AND METHODS: An interventional case series. All cases were atrophia bulbi. The axial lengths (AL) of atrophic and contralateral normal eye were measured. It was planned to use implant 3 mm smaller than AL of the contralateral normal eye. Four petals evisceration was used in all cases. RESULTS: Twenty cases were included. The mean age was 27.08 ± 16.07 years. The mean axial length (AL) of atrophic eyes was 16.97 ± 1.42 mm. In 75% of cases, the planned implant was inserted. In all cases, the implant diameter was larger than AL of atrophic eye by a mean of 2.57 ± 0.64 mm. The AL of atrophic eye did not affect the implant size. The mean follow-up period was 22.4 ± 10.1 months. Implant exposure was not recorded in any case. Volume deficiency was recorded in 2 cases (10%). CONCLUSIONS: Four petals evisceration facilitated the use of suitable sized implant in atrophia bulbi with minimal complications.
Key concepts: Evisceration (ophthalmology), Medicine, Implant, Surgery, Phthisis bulbi, Ophthalmology, Visual acuity, Pathology